We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
+$29.1B
Cap. Flow
-$16.6B
Cap. Flow %
-3.43%
Top 10 Hldgs %
36.47%
Holding
15,826
New
1,205
Increased
5,575
Reduced
7,223
Closed
1,562

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$545M
2
DXCM icon
DexCom
DXCM
+$457M
3
T icon
AT&T
T
+$431M
4
PANW icon
Palo Alto Networks
PANW
+$416M
5
HUM icon
Humana
HUM
+$394M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Healthcare 2.92%
3 Consumer Discretionary 1.99%
4 Financials 1.93%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBEV icon
13101
CALL
Splash Beverage Group
SBEV
$2.55M
$10.8K ﹤0.01%
60
-46
-43% -$8.41K
MRTN icon
13102
CALL
Marten Transport
MRTN
$1.24B
$10.8K ﹤0.01%
500
-800
-62% -$16.8K
BEEM icon
13103
Beam Global
BEEM
$25.1M
$10.7K ﹤0.01%
1,036
-7,976
-89% -$87.3K
MAPS
13104
PUT
DELISTED
WM TECHNOLOGY INC A
MAPS
$10.7K ﹤0.01%
12,800
-1,800
-12% -$1.47K
GNPX icon
13105
CALL
Genprex
GNPX
$2.18M
-1
Closed -$37.2K
DNTH icon
13106
CALL
Dianthus Therapeutics
DNTH
$6.49B
$10.7K ﹤0.01%
881
-50
-5% -$569
UP icon
13107
CALL
Wheels Up
UP
$182M
$10.7K ﹤0.01%
456
+187
+70% +$13.2K
REET icon
13108
iShares Global REIT ETF
REET
$5.09B
$10.7K ﹤0.01%
464
-24,208
-98% -$552K
COGT icon
13109
PUT
Cogent Biosciences
COGT
$6.58B
$10.7K ﹤0.01%
900
-3,300
-79% -$37.9K
RTB
13110
PUT
RTB Digital
RTB
$237M
$10.7K ﹤0.01%
41
-67
-62% -$14.6K
PMVP icon
13111
CALL
PMV Pharmaceuticals
PMVP
$67.2M
$10.6K ﹤0.01%
1,700
+1,400
+467% +$7.34K
CDXS icon
13112
PUT
Codexis
CDXS
$171M
$10.6K ﹤0.01%
3,800
-14,200
-79% -$45.9K
EWD icon
13113
PUT
iShares MSCI Sweden ETF
EWD
$587M
$10.6K ﹤0.01%
300
-1,900
-86% -$67.9K
THCH icon
13114
CALL
TH International
THCH
$50.9M
$10.6K ﹤0.01%
+740
New +$13.3K
ELDN icon
13115
Eledon Pharmaceuticals
ELDN
$288M
$10.6K ﹤0.01%
7,740
-23,070
-75% -$48.1K
WGS icon
13116
PUT
GeneDx Holdings
WGS
$2.33B
$10.6K ﹤0.01%
1,776
+424
+31% +$3.36K
TFFP
13117
CALL
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$10.5K ﹤0.01%
896
-952
-52% -$13.7K
SVVC
13118
CALL
DELISTED
Firsthand Technology Value Fund, Inc. Common Stock
SVVC
$10.5K ﹤0.01%
16,700
+8,400
+101% +$7.1K
CIG icon
13119
PUT
CEMIG Preferred Shares
CIG
$5.52B
$10.5K ﹤0.01%
+5,200
New +$9.76K
ASYS icon
13120
PUT
Amtech Systems
ASYS
$281M
$10.5K ﹤0.01%
1,100
-3,500
-76% -$31.8K
ORLA
13121
PUT
DELISTED
Orla Mining
ORLA
$10.5K ﹤0.01%
2,500
+1,300
+108% +$5.79K
ARTEW
13122
DELISTED
Artemis Strategic Investment Corporation Warrant
ARTEW
$10.5K ﹤0.01%
359,650
-15,450
-4% -$698
CLLS
13123
CALL
Cellectis
CLLS
$307M
$10.4K ﹤0.01%
+5,300
New +$10.2K
BIS icon
13124
PUT
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.09M
$10.4K ﹤0.01%
250
-150
-38% -$5.95K
BHIL
13125
DELISTED
Benson Hill, Inc.
BHIL
$10.4K ﹤0.01%
229
-901
-80% -$38.6K

Similar funds

Ken Griffin's Q2 2023 Portfolio in Review

As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.

  • Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
  • Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
  • Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
  • Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
  • Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
  • Ken Griffin opened 1,205 new positions and closed 1,562 in Q2 2023.
  • Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.